Related Experiment Video
Updated: Jun 30, 2026
07:37
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy
Laura Broglio1, Beat Erne, Markus Tolnay
1Institute of Neurobiology, Department of Research, University Hospital Basel, Basel, Switzerland.
Muscle & Nerve
|September 26, 2008
Summary
Allograft inflammatory factor-1 (AIF-1) is elevated in nerve inflammation, particularly vasculitic neuropathy. This cytokine may drive vascular smooth muscle cell proliferation, suggesting AIF-1 as a potential therapeutic target for nerve diseases.
Area of Science:
- Immunology
- Neurology
- Pathology
Background:
- Allograft inflammatory factor-1 (AIF-1) is a cytokine implicated in immune responses and vasculopathy.
- Chronic allograft rejection involves immune responses and proliferative vasculopathy.
Purpose of the Study:
- To investigate the cellular expression and pathogenetic role of AIF-1 in nerve biopsies from patients with vasculitic neuropathy.
- To compare AIF-1 expression in vasculitic neuropathy with other neuropathies and control nerves.
Main Methods:
- Immunohistochemistry was used to analyze AIF-1 expression in human nerve biopsies.
- Patient groups included vasculitic neuropathies (VASs), chronic inflammatory demyelinating polyneuropathies (CIDPs), noninflammatory axonal neuropathies (NIANs), and control nerves (CNs).
Main Results:
- AIF-1 expression was significantly higher in CIDP and VAS nerves compared to CN and NIAN nerves.
- Arterial AIF-1 levels were elevated in VAS compared to CIDP nerves.
- Vascular smooth muscle cells in vasculitic nerves showed higher AIF-1 expression than in CIDP and NIAN nerves.
Conclusions:
- AIF-1 is involved in inflammatory nerve diseases, including vasculitic neuropathy.
- AIF-1 expression correlates with vascular smooth muscle cell proliferation in these conditions.
- AIF-1 represents a potential molecular target for treating inflammatory nerve disorders and associated vasculopathy.
Related Concept Videos
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...